Both in Pharmaceuticals
Actuate Therapeutics vs Lantern Pharma
Over the past year ACTU returned −94.5% and LTRN returned −84.2%; their daily moves had a correlation of 0.13.
ACTU −94.5% LTRN −84.2%Growth of $1, one year, split-adjusted
| Metric | ACTU | LTRN |
|---|---|---|
| Price | $0.3995 | $0.6400 |
| Market cap | $9.6M | $9.6M |
| Today | −24.32% | +2.60% |
| 1 month | −45.7% | −41.3% |
| 6 months | −86.2% | −71.4% |
| Year to date | −93.5% | −78.9% |
| 1 year | −94.5% | −84.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.4M | $7.4M |
| Dividend yield | — | — |
| Volatility (60d) | 163.3% | 81.4% |
| Short % of float | 19.2% | 3.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).